Form D · Biotechnology
ALLIEDPATH, INC
San Diego, CA · CIK 0001449759
Offering snapshot reported May 20, 2010 · SEC filing
- Reported sold
- $490K Offering amount: $490K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2010 | Initial | $490,000 | No comparison | 2 | SEC filing |
| May 20, 2010 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Nov 5, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142372
Source: Form D, filed May 20, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roberta L. Della Vedova | Director, Executive |
| Heiner Dreismann, Ph.D. | Director |
| Philip J. Ginsburg, M.D. | Director, Executive |
| Bruce A. Huebner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10455 Pacific Center Court
San Diego, CA, 92121-4339
San Diego, CA, 92121-4339